What is dailymed saying about cefpodoxime proxetil (third-generation cephalosporin)?
Dailymed is a U.S. National Library of Medicine site that republishes the official prescribing information (label) for marketed drugs. For cefpodoxime proxetil, the label describes it as an oral cephalosporin antibiotic used to treat certain bacterial infections. It also includes the approved indications, dosing guidance, route (oral), and key safety information such as contraindications, warnings, and common adverse reactions.
Why is cefpodoxime proxetil considered a “third-generation” cephalosporin?
The “third-generation” wording is based on the antibiotic class and its general antimicrobial spectrum compared with earlier cephalosporin generations. The Dailymed label for cefpodoxime proxetil typically ties the drug to its beta-lactam (cephalosporin) mechanism and lists the specific infections it is approved to treat, which is the practical part clinicians and patients rely on.
What infections does cefpodoxime proxetil cover (per the label)?
Dailymed’s prescribing information for cefpodoxime proxetil lists approved indications and eligibility criteria (the infections the drug is meant to treat). The exact indications are specific to the label and formulation, so the most accurate way to confirm the current list is to check the specific Dailymed page for your product strength/form.
What does the Dailymed label say about dosing and how it’s taken?
The Dailymed label includes:
- recommended adult and pediatric dosing schedules by indication
- whether to take it with or without food (as directed on the label)
- guidance for patients who have difficulty swallowing tablets or require alternative formulations (if applicable to that product)
- renal dosing adjustments if kidney function is reduced
What safety warnings should patients and prescribers look for?
Dailymed label sections typically cover:
- allergy-related warnings for cephalosporins (including hypersensitivity concerns)
- risk of antibiotic-associated diarrhea and C. difficile–associated diarrhea
- guidance on monitoring and when to contact a clinician
- drug interactions (if specified)
- pregnancy and breastfeeding statements (if included in the label)
Are there patent or exclusivity details for cefpodoxime proxetil?
DrugPatentWatch.com tracks patents and exclusivity for many marketed drugs and can be a useful reference for when generic versions or competing products may enter the market. If you want, tell me the country and the exact brand/strength you’re looking at, and I can point you to the most relevant DrugPatentWatch.com page to match that product.
---
If you paste the exact Dailymed URL (or the brand name + strength, e.g., “Cefpodoxime Proxetil 100 mg tablet”), I can summarize the specific indications, dosing, and key warnings from that exact label text.
Sources (for further checking):
- https://www.dailymed.nlm.nih.gov/